These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12495797)

  • 1. Behavioral naltrexone therapy: an integrated treatment for opiate dependence.
    Rothenberg JL; Sullivan MA; Church SH; Seracini A; Collins E; Kleber HD; Nunes EV
    J Subst Abuse Treat; 2002 Dec; 23(4):351-60. PubMed ID: 12495797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence.
    Church SH; Rothenberg JL; Sullivan MA; Bornstein G; Nunes EV
    Am J Drug Alcohol Abuse; 2001 Aug; 27(3):441-52. PubMed ID: 11506261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients.
    Mysels DJ; Vosburg SK; Benga I; Levin FR; Sullivan MA
    J Opioid Manag; 2011; 7(1):47-53. PubMed ID: 21434584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.
    Sullivan MA; Bisaga A; Glass A; Mishlen K; Pavlicova M; Carpenter KM; Mariani JJ; Levin FR; Nunes EV
    Drug Alcohol Depend; 2015 Feb; 147():122-9. PubMed ID: 25555621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention in medication-assisted treatment for opiate dependence: A systematic review.
    Timko C; Schultz NR; Cucciare MA; Vittorio L; Garrison-Diehn C
    J Addict Dis; 2016; 35(1):22-35. PubMed ID: 26467975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.
    Carpenter KM; Jiang H; Sullivan MA; Bisaga A; Comer SD; Raby WN; Brooks AC; Nunes EV
    Psychol Addict Behav; 2009 Mar; 23(1):47-55. PubMed ID: 19290689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can psychotherapy rescue naltrexone treatment of opioid addiction?
    Rounsaville BJ
    NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
    Carroll KM; Ball SA; Nich C; O'Connor PG; Eagan DA; Frankforter TL; Triffleman EG; Shi J; Rounsaville BJ
    Arch Gen Psychiatry; 2001 Aug; 58(8):755-61. PubMed ID: 11483141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Stitzer ML
    Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of very low-dose naltrexone during opiate detoxification.
    Mannelli P; Gottheil E; Buonanno A; De Risio S
    J Addict Dis; 2003; 22(2):63-70. PubMed ID: 12703669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 16. Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.
    Jhugroo A; Ellayah D; Norman A; Hulse G
    J Psychopharmacol; 2014 Aug; 28(8):800-3. PubMed ID: 24695742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
    Jones HE; Chisolm MS; Jansson LM; Terplan M
    Addiction; 2013 Feb; 108(2):233-47. PubMed ID: 22471668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available.
    Krupitsky E; Zvartau E; Woody G
    Curr Psychiatry Rep; 2010 Oct; 12(5):448-53. PubMed ID: 20640538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 20. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.